Clinical presentations and outcomes and results of laboratory evaluation of marrow specimens, including MUM1/IRF4
Patient . | MUM1 . | Age at diagnosis . | Sex . | Rai stage . | Chemotherapy . | Marrow pattern . | Marrow involvement, % . | Vital status . | Follow-up (mo) . | Mutation status . |
---|---|---|---|---|---|---|---|---|---|---|
1 | Neg | 55 | M | Low | Yes | D | 100 | Dead | 107 | Nonmutated |
2 | Neg | 44 | M | Low | Yes | D | 100 | Dead | 69 | No clonal sequence* |
3 | Neg | 72 | F | Low | Yes | I/N | 50 | Dead | 23 | Mutated |
4 | Neg | 67 | F | Low | No | I/N | 70 | Alive | 62 | Mutated |
5 | Neg | 67 | F | Low | Yes | D | 100 | Dead | 103 | Nonmutated |
6 | Neg | 66 | M | High | Yes | I/N | 70 | Dead | 89 | Nonmutated |
7 | Neg | 79 | M | High | Yes | I/N | 50 | Dead | 41 | No clonal sequence |
8 | Neg | 70 | F | High | Yes | D | 100 | Dead | 86 | Mutated |
9 | Neg | 77 | M | High | No | D | 80 | Dead | 2 | No clonal sequence |
10 | Neg | 67 | M | Low | Yes | I/N | 60 | Dead | 80 | Nonmutated |
11 | Neg | 63 | F | Low | No | I/N | 70 | Dead | 87 | Mutated |
12 | Neg | 78 | M | Low | Yes | I/N | 60 | Dead | 57 | Nonmutated |
13 | Neg | 69 | M | High | Yes | I/N | 50 | Alive | 40 | Mutated |
14 | Neg | 61 | F | High | Yes | D | 100 | Dead | 17 | Nonmutated |
15 | Neg | 69 | M | High | No | D | 85 | Dead | 1 | No clonal sequence |
16 | Neg | 79 | M | High | No | D | 90 | Dead | 7 | Mutated |
17 | Neg | 44 | M | High | Yes | D | 100 | Alive | 35 | Mutated |
18 | Neg | 63 | M | Low | Yes | D | 70 | Dead | 63 | Nonmutated |
19 | Pos | 66 | M | Low | No | I/N | 70 | Alive | 80 | Mutated |
20 | Pos | 69 | M | Low | Yes | I/N | 25 | Alive | 100 | Mutated |
21 | Pos | 71 | M | Low | Yes | I/N | 40 | Alive | 25 | Mutated |
22 | Pos | 29 | F | Low | Yes | I/N | 60 | Alive | 95 | Mutated |
23 | Pos | 47 | F | Low | No | I/N | 10 | Alive | 70 | Mutated |
24 | Pos | 50 | F | Low | Yes | I/N | 20 | Alive | 37 | Nonmutated |
25 | Pos | 55 | F | Low | No | I/N | 50 | Alive | 28 | Mutated |
26 | Pos | 60 | F | Low | No | I/N | 60 | Alive | 64 | Mutated |
27 | Pos | 60 | F | Low | No | I/N | 5 | Alive | 84 | No clonal sequence |
28 | Pos | 35 | M | Low | Yes | I/N | 10 | Dead | 67 | Not done |
29 | Pos | 74 | M | Low | Yes | D | 80 | Dead | 40 | No clonal sequence |
30 | Pos | 65 | M | High | No | I/N | 10 | Alive | 76 | No clonal sequence |
Patient . | MUM1 . | Age at diagnosis . | Sex . | Rai stage . | Chemotherapy . | Marrow pattern . | Marrow involvement, % . | Vital status . | Follow-up (mo) . | Mutation status . |
---|---|---|---|---|---|---|---|---|---|---|
1 | Neg | 55 | M | Low | Yes | D | 100 | Dead | 107 | Nonmutated |
2 | Neg | 44 | M | Low | Yes | D | 100 | Dead | 69 | No clonal sequence* |
3 | Neg | 72 | F | Low | Yes | I/N | 50 | Dead | 23 | Mutated |
4 | Neg | 67 | F | Low | No | I/N | 70 | Alive | 62 | Mutated |
5 | Neg | 67 | F | Low | Yes | D | 100 | Dead | 103 | Nonmutated |
6 | Neg | 66 | M | High | Yes | I/N | 70 | Dead | 89 | Nonmutated |
7 | Neg | 79 | M | High | Yes | I/N | 50 | Dead | 41 | No clonal sequence |
8 | Neg | 70 | F | High | Yes | D | 100 | Dead | 86 | Mutated |
9 | Neg | 77 | M | High | No | D | 80 | Dead | 2 | No clonal sequence |
10 | Neg | 67 | M | Low | Yes | I/N | 60 | Dead | 80 | Nonmutated |
11 | Neg | 63 | F | Low | No | I/N | 70 | Dead | 87 | Mutated |
12 | Neg | 78 | M | Low | Yes | I/N | 60 | Dead | 57 | Nonmutated |
13 | Neg | 69 | M | High | Yes | I/N | 50 | Alive | 40 | Mutated |
14 | Neg | 61 | F | High | Yes | D | 100 | Dead | 17 | Nonmutated |
15 | Neg | 69 | M | High | No | D | 85 | Dead | 1 | No clonal sequence |
16 | Neg | 79 | M | High | No | D | 90 | Dead | 7 | Mutated |
17 | Neg | 44 | M | High | Yes | D | 100 | Alive | 35 | Mutated |
18 | Neg | 63 | M | Low | Yes | D | 70 | Dead | 63 | Nonmutated |
19 | Pos | 66 | M | Low | No | I/N | 70 | Alive | 80 | Mutated |
20 | Pos | 69 | M | Low | Yes | I/N | 25 | Alive | 100 | Mutated |
21 | Pos | 71 | M | Low | Yes | I/N | 40 | Alive | 25 | Mutated |
22 | Pos | 29 | F | Low | Yes | I/N | 60 | Alive | 95 | Mutated |
23 | Pos | 47 | F | Low | No | I/N | 10 | Alive | 70 | Mutated |
24 | Pos | 50 | F | Low | Yes | I/N | 20 | Alive | 37 | Nonmutated |
25 | Pos | 55 | F | Low | No | I/N | 50 | Alive | 28 | Mutated |
26 | Pos | 60 | F | Low | No | I/N | 60 | Alive | 64 | Mutated |
27 | Pos | 60 | F | Low | No | I/N | 5 | Alive | 84 | No clonal sequence |
28 | Pos | 35 | M | Low | Yes | I/N | 10 | Dead | 67 | Not done |
29 | Pos | 74 | M | Low | Yes | D | 80 | Dead | 40 | No clonal sequence |
30 | Pos | 65 | M | High | No | I/N | 10 | Alive | 76 | No clonal sequence |
D indicates diffuse; dx, diagnosis; I/N, interstitial and/or nodular; Neg, negative; and Pos, positive.
No clonal band was identified for sequencing